General MedicationsVIALStandard
PROLEUKIN
ALDESLEUKIN
Standard Dose
22MIU/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PROLEUKIN is listed in Drugs@FDA under application 103293 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ALDESLEUKIN Form and strength VIAL - 22MIU/VIAL Sponsor CHIRON Submission history Latest submission status date: 2023-09-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview PROLEUKIN is listed in Drugs@FDA under application 103293 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ALDESLEUKIN Form and strength VIAL - 22MIU/VIAL Sponsor CHIRON Submission history Latest submission status date: 2023-09-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.